Clinical Trial Update: Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of high-dose dual therapy and bismuth quadruple therapy for Helicobacter pylori eradication on intestinal microecology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyspepsia
• Gastric Cancer
• Gastritis
• Helicobacter Pylori Infection
• Peptic Ulcer Disease

Snippet

Sponsor: Xijing Hospital of Digestive Diseases | Conditions: Gastritis, Dyspepsia | Phase 4 | Status: COMPLETED